OGN Organon & Co

添加自选

18.830
+0.220+1.18%

收盘价 05/01 16:00 (美东)

18.800
-0.030-0.16%

盘后 18:36 (美东)

48.43亿总市值4.72市盈率TTM

关于Organon & Co公司

Organon & Co 是一家以科学为基础的全球制药公司，通过妇女保健，生物仿制药和知名品牌的处方治疗组合，开发和提供健康解决方案。公司的业务包括以下产品组合：妇女保健，生物仿制药和成熟药品。从地域上看，公司大部分收入来自欧洲和加拿大，其次是美国，再次是亚太地区和日本。公司的大部分收入来自成熟品牌产品组合。

公司介绍

公司代码OGN

公司名称Organon & Co

上市日期2021/05/14

成立日期2020

CEOMr. Kevin Ali

所属市场纽交所

员工数量10000

证券类型海外普通股

年结日12-31

公司地址30 Hudson Street,33rd floor

城市Jersey City

省份新泽西

国家美国

邮编07302

电话1-551-430-6900

网址http://www.organon.com

董事高管

姓名
职务
年薪

Kevin Ali
Chief Executive Officer and Director
1483.23万

Dr. Juan Camilo Arjona Ferreira, M.D.
Executive Vice President, Head of Research and Development and Chief Medical Officer
--

Susanne Fiedler
Executive Vice President and Chief Commercial Officer
383.64万

Rachel A. Stahler
Executive Vice President and Chief Information Officer
--

Matthew M. Walsh
Executive Vice President and Chief Financial Officer
521.29万

Aaron Falcione
Executive Vice President and Chief Human Resources Officer
--

Vittorio Nisita
Executive Vice President and Head of Global Business Services
--

Kirke Weaver
Executive Vice President, General Counsel and Corporate Secretary
319.27万

Joseph T. Morrissey, Jr
Executive Vice President and Head of Manufacturing and Supply
373.70万

Carrie S. Cox
Chairman of the Board
45.00万

Martha E. McGarry
Independent Director
32.00万

Grace Puma Whiteford
Independent Director
32.00万

Deborah R. Leone
Independent Director
33.00万

Shalini Sharp
Independent Director
34.50万

Rochelle B. Lazarus
Independent Director
32.00万

Dr. Phillip Ozuah, M.D.,PhD
Independent Director
32.00万

Dr. Helene D. Gayle, M.D.
Independent Director
32.00万

Cynthia M. Patton
Independent Director
33.00万

Fatima Ma. Francisco
Independent Director
32.00万

Dr. Alan Ezekowitz, D.Phil.,MB.Ch.B.
Independent Director
33.00万

Robert A. Essner
Independent Director
33.50万

分析

分析师评级

暂无数据

目标价预测

暂无数据

热议

美股

综合热度